Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Edgren

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Plos One|May 5, 2023
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinomaMarko Salmikangas, Maria Laaksonen, Henrik Edgren, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Carcinogenesis|May 22, 2013
Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including Twist2 upregulationGunilla Högnäs, Saara Hämälistö, Kirsi Rilla, et al.
Breast Cancer Research and Treatment|March 31, 2010
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesisSirkku Pollari, Sanna-Maria Käkönen, Henrik Edgren, et al.
Bioinformatics (Oxford, England)|November 5, 2003
A novel strategy for microarray quality control using Bayesian networksSampsa Hautaniemi, Henrik Edgren, Petri Vesanen, et al.
Oncotarget|July 25, 2018
RET fusions observed in lung and colorectal cancers are sensitive to ponatinibJoseph M Gozgit, Tzu-Hsiu Chen, Youngchul Song, et al.
Experimental Cell Research|December 26, 2009
Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cellsHeather Main, Kian Leong Lee, Henry Yang, et al.
Leukemia & Lymphoma|August 5, 2017
Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemiaJarno L Kivioja, Jesus M Lopez Martí, Ashwini Kumar, et al.
Breast Cancer (Dove Medical Press)|March 31, 2017
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment responseSandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, et al.
Cancer Research|November 3, 2006
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingKristiina Iljin, Maija Wolf, Henrik Edgren, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Plos One|May 5, 2023
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinomaMarko Salmikangas, Maria Laaksonen, Henrik Edgren, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Carcinogenesis|May 22, 2013
Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including Twist2 upregulationGunilla Högnäs, Saara Hämälistö, Kirsi Rilla, et al.
Breast Cancer Research and Treatment|March 31, 2010
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesisSirkku Pollari, Sanna-Maria Käkönen, Henrik Edgren, et al.
Bioinformatics (Oxford, England)|November 5, 2003
A novel strategy for microarray quality control using Bayesian networksSampsa Hautaniemi, Henrik Edgren, Petri Vesanen, et al.
Oncotarget|July 25, 2018
RET fusions observed in lung and colorectal cancers are sensitive to ponatinibJoseph M Gozgit, Tzu-Hsiu Chen, Youngchul Song, et al.
Experimental Cell Research|December 26, 2009
Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cellsHeather Main, Kian Leong Lee, Henry Yang, et al.
Leukemia & Lymphoma|August 5, 2017
Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemiaJarno L Kivioja, Jesus M Lopez Martí, Ashwini Kumar, et al.
Breast Cancer (Dove Medical Press)|March 31, 2017
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment responseSandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, et al.
Cancer Research|November 3, 2006
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingKristiina Iljin, Maija Wolf, Henrik Edgren, et al.
Pageof 4